TOBRAMYCIN INJECTION USP 40mg/ml(2021-06-21)
- Starting date:
- June 21, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-75897
Last updated:
2021-06-24
Summary
-
Product:
TOBRAMYCIN INJECTION USP 40mg/ml
Reason
The assay results for antioxidant, sodium metabisulfite, is out of specification in the affected lot.
Depth of distribution
Retailers, Wholesalers
Affected products
TOBRAMYCIN INJECTION USP 40mg/ml
DIN, NPN, DIN-HIM
DIN 02502372
Dosage form
Solution
Strength
TOBRAMYCIN (TOBRAMYCIN SULFATE) 40 MG / ML
Lot or serial number
AEP002
Companies
- Recalling Firm
-
Sterimax Inc.
2770 Portland Drive
Oakville
L6H 6R4
Ontario
CANADA
- Marketing Authorization Holder
-
Sterimax Inc.
2770 Portland Drive
Oakville
L6H 6R4
Ontario
CANADA